Alleviant Medical, Inc.
Implantable interatrial shunt device for left atrial decompression in heart failure
- Sector
- Medtech
- Headquarters
- AUSTIN, TX
- Founded
- 2017
- Latest Form D
- $90.8M, Jan 2025
- Total capital
- $147M
- Federal grants
- $5.2M
- 6 awards · 2018–2026
- Rank in peer group#145 of 538
- Private capital raised
- $142M
- 4 Form D · last Jan 2025
- 21 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 10 pending · first 2022
- Rank in peer group#125 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$996K
- Federal grantHealth and Human S · Phase II · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$993K
- Private capital raisedForm D · SEC · 4th filing$90.8M
- Federal grantHealth and Human S · Phase II · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$998K
- Federal grantHealth and Human S · Phase II · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$1M
- Private capital raisedForm D · SEC · 3rd filing$43.9M
- Federal grantHealth and Human S · Phase II · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$899K
- Private capital raisedForm D · SEC · 2nd filing$6.5M
- Private capital raisedForm D · SEC · 1st filing$1.1M
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression$314K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#145 · top 27%
- Granted patents#125 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Christopher Alex ArevalosResearcherExecutive Officer, DirectorLinked by $314K in grants as PI
- Adam BermanExecutive Officer, DirectorNamed in SEC Form D filings
- Albertien Alex GreijdanusExecutive Officer, DirectorNamed in SEC Form D filings
- Ashok GowdaDirectorNamed in SEC Form D filings
- Avni Alex PatelExecutive Officer, DirectorNamed in SEC Form D filings
- Brian R SmithDirectorNamed in SEC Form D filings
Show all 16 people
- Christopher KasterDirectorNamed in SEC Form D filings
- Geoff R PardoDirectorNamed in SEC Form D filings
- Gowda R AshokDirectorNamed in SEC Form D filings
- Ian R MeredithDirectorNamed in SEC Form D filings
- Jacob KriegelExecutive Officer, DirectorNamed in SEC Form D filings
- Jay R SchmelterDirectorNamed in SEC Form D filings
- Kirk R NielsenDirectorNamed in SEC Form D filings
- Kirk R NielsonDirectorNamed in SEC Form D filings
- Maria R BerkmanDirectorNamed in SEC Form D filings
- Mary ByronDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 14- PendingTranscatheter Device For Interatrial AnastomosisUSPTOApplication 19173471
- GrantedTranscatheter Device For Interatrial AnastomosisUSPTOUS 12,290,305
- GrantedSystems, Devices, And Methods For Forming An AnastomosisUSPTOUS 11,871,987
Show all 14 patent records
- Transcatheter Device For Interatrial AnastomosisFeb 26, 2026 · Application 19173471Pending
- Transcatheter Device For Interatrial AnastomosisMay 6, 2025 · US 12,290,305Granted
- Systems, Devices, And Methods For Forming An AnastomosisJan 16, 2024 · US 11,871,987Granted
- Systems, Devices, And Methods For Forming An AnastomosisMar 28, 2023 · US 11,612,432Granted
- Systems, Devices, And Methods For Diagnosing AmyloidosisJul 7, 2022 · Application 17569383Pending
- Systems, Devices, And Methods For Forming An AnastomosisApr 19, 2022 · US 11,304,753Granted
- Systems, Devices, And Methods For Forming An AnastomosisMar 18, 2021 · Application 17019042Pending
- Systems, Devices, And Methods For Forming An AnastomosisApplication PCTUS2020050533Pending
- Systems, Devices, And Methods For Diagnosing AmyloidosisApplication 63134822Pending
- Systems, Devices, And Methods For Forming An AnastomosisApplication 62971357Pending
- Systems, Devices, And Methods For Forming An AnastomosisApplication 62900034Pending
- Transcatheter Device For Interatrial AnastomosisApplication PCTUS2018063439Pending
- Transcatheter Device For Interatrial AnastomosisApplication 62715922Pending
- Transcatheter Device For Interatrial AnastomosisApplication 62592630Pending
Related companies, and why
- Sersense IncSimilar federal contract value in Medtech · null in contracts
- EmpNia Inc.Similar federal contract value in Medtech · null in contracts
- Psychology Software Tools, Inc.Similar federal contract value in Medtech · null in contracts
- Allied Polymer Innovations IncSimilar federal contract value in Medtech · null in contracts
- VOXELERON, LLCSimilar federal contract value in Medtech · null in contracts
- ALZECA BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .